These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

928 related items for PubMed ID: 18021088

  • 1. Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma: emphasis on risk factors for progression.
    Kyle RA, Rajkumar SV.
    Br J Haematol; 2007 Dec; 139(5):730-43. PubMed ID: 18021088
    [Abstract] [Full Text] [Related]

  • 2. Monoclonal gammopathies of undetermined significance.
    Kyle RA, Rajkumar SV.
    Best Pract Res Clin Haematol; 2005 Dec; 18(4):689-707. PubMed ID: 16026745
    [Abstract] [Full Text] [Related]

  • 3. Pathogenesis and progression of monoclonal gammopathy of undetermined significance.
    Bladé J, Rosiñol L, Cibeira MT, de Larrea CF.
    Leukemia; 2008 Sep; 22(9):1651-7. PubMed ID: 18668131
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Monoclonal gammopathy of undetermined significance].
    Chaïbi P, Merlin L, Thomas C, Piette F.
    Ann Med Interne (Paris); 2002 Nov; 153(7):459-66. PubMed ID: 12598832
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Incidence and evolution of monoclonal gammopathy of undetermined significance (MGUS) in Greece.
    Anagnostopoulos A, Evangelopoulou A, Sotou D, Gika D, Mitsibounas D, Dimopoulos MA.
    Ann Hematol; 2002 Jul; 81(7):357-61. PubMed ID: 12185503
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Kyle RA, San-Miguel JF, Mateos MV, Rajkumar SV.
    Hematol Oncol Clin North Am; 2014 Oct; 28(5):775-90. PubMed ID: 25212882
    [Abstract] [Full Text] [Related]

  • 11. [Monoclonal gammopathies of undetermined significance].
    Krizalkovicová V, Maisnar V, Pour L, Radocha J, Hájek R.
    Klin Onkol; 2008 Oct; 21(4):160-4. PubMed ID: 19102222
    [Abstract] [Full Text] [Related]

  • 12. [Benign monoclonal gammopathy].
    Shirota T, Kondo M, Uchida H, Ito H.
    Nihon Rinsho; 1995 Mar; 53(3):720-4. PubMed ID: 7699912
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Diagnostic criteria of multiple myeloma.
    Kyle RA.
    Hematol Oncol Clin North Am; 1992 Apr; 6(2):347-58. PubMed ID: 1582977
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The incidental monoclonal protein: current approach to management of monoclonal gammopathy of undetermined significance (MGUS).
    Madan S, Greipp PR.
    Blood Rev; 2009 Nov; 23(6):257-65. PubMed ID: 19699016
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Risk of progression in smouldering myeloma and monoclonal gammopathies of unknown significance: comparative analysis of the evolution of monoclonal component and multiparameter flow cytometry of bone marrow plasma cells.
    Pérez-Persona E, Mateo G, García-Sanz R, Mateos MV, de Las Heras N, de Coca AG, Hernández JM, Galende J, Martín-Nuñez G, Bárez A, Alonso JM, Martín A, López-Berges C, Orfao A, San Miguel JF, Vidriales MB.
    Br J Haematol; 2010 Jan; 148(1):110-4. PubMed ID: 19821821
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.